Literature DB >> 24414178

Differential expression of the alternatively spliced forms of prosaposin mRNAs in rat choroid plexus.

Shouichiro Saito1, Kyoko Saito, Hiroaki Nabeka, Tetsuya Shimokawa, Naoto Kobayashi, Seiji Matsuda.   

Abstract

Prosaposin has two distinct profiles. One is a precursor form that is processed into saposins thus promoting lysosomal sphingolipid hydrolase function, whereas the other is an intact form that is not processed into saposins but is abundant in certain tissues and secretory fluids, including the cerebrospinal fluid. In rats, alternative splicing in the prosaposin gene generates mRNAs with and without a 9-base insertion (Pro+9 and Pro+0 mRNAs, respectively). Pro+9 mRNA is reported to be preferentially expressed in tissues in which the intact form of prosaposin dominates, whereas Pro+0 mRNA is preferentially expressed in tissues in which the precursor dominates. The expression patterns of Pro+9 and Pro+0 mRNAs in the rat choroid plexus are examined in the present study. The specificities of 36-mer oligonucleotide probes used to detect the 9-base insertion by in situ hybridization were demonstrated by dot-blot hybridization. Next, these probes were used for in situ hybridization, which showed predominant expression of Pro+0 mRNA and weak expression of Pro+9 mRNA in the choroid plexus. These expression patterns were confirmed by reverse transcription plus the polymerase chain reaction with AlwI restriction enzyme treatment. Expression of the intact form of prosaposin in the choroid plexus was assessed by Western blotting and immunohistochemistry. Because the choroid plexus is responsible for the generation of cerebrospinal fluid containing the intact form of prosaposin, the present study raises the possibility that Pro+0 mRNA is related to the intact form in the choroid plexus and that the alternatively spliced forms of mRNAs do not simply correspond to the precursor and intact forms of prosaposin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24414178     DOI: 10.1007/s00441-013-1773-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

Review 1.  Prosaposin, a neurotrophic factor, protects neurons against kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka
Journal:  Anat Sci Int       Date:  2021-02-03       Impact factor: 1.741

2.  Prosaposin in the rat oviductal epithelial cells.

Authors:  Tetsuya Shimokawa; Hiroaki Nabeka; Sakirul Islam Khan; Kimiko Yamamiya; Takuya Doihara; Naoto Kobayashi; Hiroyuki Wakisaka; Seiji Matsuda
Journal:  Cell Tissue Res       Date:  2020-11-26       Impact factor: 5.249

3.  Prosaposin overexpression following kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka; Keigo Uematsu; Hiroko Takechi; Tetsuya Shimokawa; Kimiko Yamamiya; Cheng Li; Takuya Doihara; Shouichiro Saito; Naoto Kobayashi; Seiji Matsuda
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

4.  A prosaposin-derived Peptide alleviates kainic Acid-induced brain injury.

Authors:  Hiroaki Nabeka; Tetsuya Shimokawa; Takuya Doihara; Shouichiro Saito; Hiroyuki Wakisaka; Fumihiko Hamada; Naoto Kobayashi; Seiji Matsuda
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

5.  Expression of prosaposin and its receptors in the rat cerebellum after kainic acid injection.

Authors:  Xuan Li; Hiroaki Nabeka; Shouichiro Saito; Tetsuya Shimokawa; Md Sakirul Islam Khan; Kimiko Yamamiya; Fengping Shan; Huiling Gao; Cheng Li; Seiji Matsuda
Journal:  IBRO Rep       Date:  2017-02-24

6.  Interneurons secrete prosaposin, a neurotrophic factor, to attenuate kainic acid-induced neurotoxicity.

Authors:  Hiroaki Nabeka; Shouichiro Saito; Xuan Li; Tetsuya Shimokawa; Md Sakirul Islam Khan; Kimiko Yamamiya; Soichiro Kawabe; Takuya Doihara; Fumihiko Hamada; Naoto Kobayashi; Seiji Matsuda
Journal:  IBRO Rep       Date:  2017-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.